GHK-Cu, the tripeptide glycyl-L-histidyl-L-lysine bound to copper, demonstrates activity at concentrations that would seem impossibly small to anyone familiar with standard peptide dosing
In clinical practice, it is common to see frustrated patients who tried oral or sublingual versions without noticing any changes in body composition, energy levels, or sleep quality
I have been using it for about a month and I am seeing steady improvement
The deviation from linearity is probably due to geometric constraints in the roGFP barrel similar to those described for roGFP1-iR which had been expected to be less reducing than roGFP1-iL due to stabilization of the thiolate anion by the introduced adjacent basic arginine residue (Lohman and Remington, For live cell measurements biosensors should ideally exhibit a strong preference for one specific analyte
Before treatment, a thorough diagnostic and analytical evaluation is carried out, including specific tests to quantify the accumulated heavy metal burden, allowing for a customized and optimized therapeutic plan
But while anecdotal results are promising, what do clinical trials actually say